PSYCHOLOGICAL ASSESSMENT INSTRUMENTS IN PATIENTS DIAGNOSED WITH CANCER
DOI:
https://doi.org/10.31243/ei.uta.v10i2.2935.2025Keywords:
cáncer, instrumentos psicológicos, pacientes adultos.Abstract
Introduction: Cancer, one of the most significant non-communicable diseases worldwide, carries various repercussions in the patient's life, especially in the emotional aspect. Objective: To identify the scientific evidence that exists regarding the different psychological assessment instruments for patients diagnosed with cancer. Methods: A scoping review was carried out following the methodological recommendations of the Joanna Briggs Institute, and the guidelines of the PRISMA ScR guide were followed for the preparation of the report. Three databases and grey literature were searched systematically, and studies were selected using Rayyan Systems software independently by both reviewers. Extracted data were analysed using basic quantitative and basic qualitative deductive content analysis. Results: 30 studies were identified that met the inclusion criteria; these instruments were grouped into categories according to the mental disorder they measure, this taking the DSM-5 as a reference, all instruments presented acceptable validity and internal consistency for use in oncology patients. Conclusions: This review highlights the importance of psychological assessment in cancer patients and provides useful guidance for selecting appropriate instruments. These findings contribute to the improvement of the comprehensive approach to cancer patients and strengthen psychological care in this context.
References
Organización Mundial de la Salud. Cáncer. 2022. Disponible en: https://www.who.int/es/news-room/fact-sheets/detail/cancer
Hernández M, Cruzado J, Prado C, Rodríguez E, Hernández C, González M, et al. Salud mental y malestar emocional en pacientes con cáncer. Psicooncología. 2012;9(2–3):233–257. DOI: https://doi.org/10.5209/rev_PSIC.2013.v9.n2-3.40895
Organización Mundial de la Salud, Organización Panamericana de la Salud. Cáncer. 2018. Disponible en: https://www.paho.org/es/temas/cancer
Ministerio de Salud Pública. Diagnóstico y detección oportunas son claves para mejorar calidad de vida de pacientes con cáncer. 2022. Disponible en: https://n9.cl/r6q89
Krikorian A. Valoración del Sufrimiento en Pacientes con Cáncer Avanzado. Psicooncología. 2008;5(2–3):257–264. Disponible en: https://revistas.ucm.es/index.php/PSIC/article/view/PSIC0808220257A
Ramírez E, Cárdenas G, Greer J, Sánchez S, Riveros A. Evaluación de la depresión en pacientes con cáncer terminal y su aplicación en el contexto mexicano: Una revisión. Revista Salud Mental. 2014;37(5):415–422. DOI: https://doi.org/10.5209/rev_PSIC.2013.v9.n2-3.40895
Arksey H, O’Malley L. Scoping studies: Towards a Methodological Framework. International Journal of Social Research Methodology: Theory and Practice. 2005;8(1):19–32. DOI: https://doi.org/10.1080/1364557032000119616
Joanna Briggs Institute. JBI Manual for Evidence Synthesis. 2020. DOI: https://doi.org/10.46658/JBIMES-24-01
Page M, McKenzie J, Bossuyt P, Boutron I, Hoffmann T, Mulrow C, et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. The BMJ. 2021;372(71):375. DOI: https://doi.org/10.1136/bmj.n71
PRISMA. PRISMA Flow Diagram. 2020. Disponible en: https://n9.cl/co4yf
Pollock D, Peters M, Khalil H, McInerney P, Alexander L, Tricco A, et al. Recommendations for the extraction, analysis, and presentation of results in scoping reviews. JBI Evid Synth. 2023;21(3):520–532. DOI: https://doi.org/10.11124/JBIES-22-00123
Elo S, Kynga¨s H. The qualitative content analysis process. Leading Global Nursing Research. 2007;62(1):107–115. DOI: https://doi.org/10.1111/j.1365-2648.2007.04569.x
Neefjes E, Van der Vorst M, Boddaert M, Verdegaal B, Beeker A, Teunissen S, et al. Accuracy of the Delirium Observational Screening Scale (DOS) as a screening tool for delirium in patients with advanced cancer. BMC Cancer. 2019;19(1):150–160. DOI: doi.org/10.1186/s12885-019-5351-8
Grassi L, Buda P, Cavana L, Annunziata M, Torta R, Varetto A. Styles of coping with cancer: the Italian version of the Mini-Mental Adjustment to Cancer (Mini-MAC) scale. Psychooncology. 2005;14(2):115–24. DOI: doi.org/10.1002/pon.826
Miraglia A, Rosapia G. Assessment of depression symptoms in female cancer patients: focus on concurrent validity. Acta Biomed. 2020;91(2):16–8. DOI: doi.org/10.23750/abm.v91i2-S.9285
Lara L, Villoria E. Assessment of the Hospital Anxiety and Depression Scale for cancer patients. Rev Med Chil. 2018;146(3):300–7. DOI: doi.org/10.4067/s0034-98872018000300300
Rooney A, McNamara S, MacKinnon M, Fraser M, Rampling R, Carson A, et al. Screening for major depressive disorder in adults with cerebral glioma: an initial validation of 3 self-report instruments. Neuro Oncol. 2013;15(1):122–129. DOI: doi.org/ 10.1093/neuonc/nos282
Montazeri A, Vahdaninia M, Ebrahimi M, Jarvandi S. The Hospital Anxiety and Depression Scale (HADS): translation and validation study of the Iranian version. Journal of Health Qual Life Outcomes. 2003;1(0):14–8. DOI: doi.org/10.1186/1477-7525-1-14
Mystakidou K, Tsilika E, Parpa E, Katsouda E, Galanos A, Vlahos L. The Hospital Anxiety and Depression Scale in Greek cancer patients: psychometric analyses and applicability. Journal of Support Care Cancer. 2004;12(12):821–825. DOI: doi.org/ 10.1007/s00520-004-0698-y
Muszbek K, Szekely A, Balogh E, Molnar M, Rohanszky M, Ruzsa A, et al. Validation of the Hungarian translation of Hospital Anxiety and Depression Scale. Journal of Qual Life Res. 2006;15(4):761–766. DOI: doi.org/10.1007/s11136-005-3627-8
Lloyd M, Friedman T, Rudd N. An Analysis of the Validity of the Hospital Anxiety and Depression Scale as a Screening Tool in Patients with Advanced Metastatic Cancer. Journal of Pain and Symptom Management. 2001;22(6):990–996. DOI: https://doi.org/10.1016/S0885-3924(01)00358-X
Lloyd M, Friedman T, Rudd N. Criterion Validation of the Edinburgh Postnatal Depression Scale as a Screening Tool for Depression in Patients with Advanced Metastatic Cancer. Journal of Pain and Symptom Management. 2000;20(4):259–265. DOI: https://doi.org/10.1016/S0885-3924(00)00182-2
Love AW, Kissane DW, Bloch S, Clarke DM. Diagnostic efficiency of the Hospital Anxiety and Depression Scale in women with early stage breast cancer. Aust N Z J Psychiatry. 2002;36(2):246–250. DOI: 10.1046/j.1440-1614.2002.01014.x
Passik S, Kirsh K, Donaghy K, Theobald D, Lundberg J, Holtsclaw E, et al. An Attempt to Employ the Zung Self-Rating Depression Scale as a “Lab Test” to Trigger Follow-Up in Ambulatory Oncology Clinics: Criterion Validity and Detection. Journal of Pain and Symptom Management. 2001;21(4):273–281. DOI: https://doi.org/10.1016/S0885-3924(00)00264-5
Grassi L, Caraceni A, Beltrami E, Borreani C, Zamorani M, Maltoni M, et al. Assessing Delirium in Cancer Patients. The Italian Versions of the Delirium Rating Scale and the Memorial Delirium Assessment Scale. Journal of Pain and Symptom Management, 2001;21(1):59–70. DOI: https://doi.org/10.1016/S0885-3924(00)00241-4
Dugan W, McDonald M, Passika S, Rosenfeld B, Theobald D, Edgerton S. Use of the Zung Self-Rating Depression Scale in cancer patients: feasibility as a screening tool. Psychooncology, 1998;7(6):483–493. DOI: 10.1002/(SICI)1099-1611(199811/12)7:6<483::AID-PON326>3.0.CO;2-M
Rodríguez O, Rodríguez B, Ascencio L, Peña A, Verástegui E, Allende S, et al. Validation of the Brief Edinburgh Depression Scale (BEDS) in a Mexican population with advanced cancer in a palliative care service. Palliative and Supportive Care. 2019;17(4):436-440. DOI:10.1017/S1478951518000640
Chhabria K, Carnaby G. Psychometric validation of the Center for Epidemiological Studies Depression Scale in Head and Neck Cancer patients. Oral Oncol. 2017;75(1):158–162. DOI: 10.1016/j.oraloncology.2017.11.010
Olagunju A, Aina O, Fadipe B. Screening for depression with Centre for Epidemiological Studies Depression Scale Revised and its implication for consultation-liaison psychiatry practice among cancer subjects: a perspective from a developing country. Psychooncology. 2013;22(8):1901–1906. DOI: 10.1002/pon.3234
Zhu L, Yao J, Wu L, Wang J, Qiu M, Zhang C, et al. Psychometric properties of the Depression Stigma Scale (DSS) in Chinese cancer patients: a crosssectional study. Revista BMJ open. 2019;9(7):200–215. DOI:10.1136/bmjopen-2018-028429
Desiree J, Thekdi S, Wang S, Fisch M, Vichaya E, Cleeland C, et al. Screening for depressed mood in patients with cancer using the MD Anderson Symptom Inventory: investigation of a practical approach for the oncologist. J Oncol Pract. 2013;10(2):95–102. DOI: 10.1200/JOP.2013.001112
Spangenberg L, Zenger M, Garcia-Torres F, Mueller V, Reck M, Mehnert A, et al. Dimensionality, stability, and validity of the Beck Hopelessness Scale in cancer patients receiving curative and palliative treatment. J Pain Symptom Manage. 2016;51(3):615–622. DOI: 10.1016/j.jpainsymman.2015.11.008
Belar A, Arantzamendi M, Rodríguez-Núñez A, Santesteban Y, Martinez M, López-Saca M, et al. Multicenter Study of the Psychometric Properties of the New Demoralization Scale (DS-II) in Spanish-Speaking Advanced Cancer Patients. J Pain Symptom Manage 2019;57(3):627–634. DOI: 10.1016/j.jpainsymman.2018.11.016
Zimmermann C, Rodin G, Hales S, Lo C, Gagliese L, Rydall A. Measuring death-related anxiety in advanced cancer: preliminary psychometrics of the Death and Dying Distress Scale. J Pediatr Hematol Oncol. 2011;33(0):140–145. DOI: 10.1097/MPH.0b013e318230e1fd
Thorvaldsdóttir G, Gunnarsdottir S, Bjarnason B, Fridriksdottir N, Skulason B, Samari J. The psychometric properties of the Icelandic version of the distress thermometer and problem list. Psychooncology. 2012;21(7):730–736. DOI: 10.1002/pon.1950
Patel D, Sharpe L, Thewes B, Bell ML, Clarke S. Using the Distress Thermometer and Hospital Anxiety and Depression Scale to screen for psychosocial morbidity in patients diagnosed with colorectal cancer. J Affect Disord. 2011;131(1–3):412–416. DOI: 10.1016/j.jad.2010.11.014
Low J, Gessler S, Williams R, Daniells E, Brough V, Tookman A, et al. Screening for distress and depression in cancer patients: is ultrashort depression screening a valid measure in the UK? A prospective validation study. J Pain Symptom Manage. 2009;38(2):234–243. DOI: 10.1016/j.jpainsymman.2008.08.006
Jacobsen P, Donovan K, Trask P, Fleishman S, Zabora J, Baker F, et al. Screening for psychologic distress in ambulatory cancer patients. Cancer. 2005;103(7):1494–1502. DOI: https://doi.org/10.1002/cncr.20940
Marten B, Book K, Buchhold B, Dinkel A, Gründobler B, Henrich G, et al. The Basic Documentation for Psycho-Oncology Short Form (PO-Bado SF) an expert rating scale for distress screening: development and psychometric properties. Psychooncology. 2015;24(6):653–660. DOI: 10.1002/pon.3708
Rodríguez L, Rubiños S. Evidencias de Validez de Contenido del Cuestionario de Afrontamiento al estrés para pacientes Oncológicos. Tesis de Grado, Universidad César Vallejo. 2020. Disponible en: https://repositorio.ucv.edu.pe/bitstream/handle/20.500.12692/55384/Rodr%c3%adguez_VLR-Rubi%c3%b1os_RSM-SD.pdf?sequence=1&isAllowed=y
Akechi T, Fukue M, Kugayad A, Okamura H, Nishiwak Y, Yamawak S, et al. Psychometric properties of the Japanese version of the Mental Adjustment to Cancer (MAC) scale. Psychooncology. 2000;9(5):395–401. DOI: 10.1002/1099-1611(200009/10)9:5<395::aid-pon472>3.0.co;2-o
Ho S, Fung WK, Chan C, Watson M, Tsui Y. Psychometric properties of the Chinese version of the Mini-Mental Adjustment to Cancer (MINI-MAC) scale. Psychooncology. 2003;12(6):547–456. DOI: 10.1002/pon.672
Pichot P, López J, Valdés M. DSM-IV: Manual diagnóstico y estadístico de los trastornos mentales. Masson; 1995. Disponible en: https://www.srmcursos.com/archivos/arch_5cab5b49f21e1.pdf
Asociación Americana de Psiquiatría. Manual Diagnóstico y Estadístico de los Trastornos Mentales DSM-5-TR. 5th ed. Editorial Médica Panamericana; 2022. Disponible en: https://n9.cl/t1hen
Barrio P, Molina O, Campos J, Franco E, Suarez A, Arreo V. Enfermería Psiquiátrica y Salud Mental. 4th ed. Academia de Estudios MIR; 2014. Disponible en: https://n9.cl/337h5j
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Enfermería Investiga
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License 4.0 that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
